Surgical Replantation

Alcon Secures Control of Aurion Biotech in Strategic Takeover

4 weeks ago talkbio0Tagged Alcon, AURN001, biotech, Bovichtus, Cell Therapy, CEO, corneal endothelial disease, IPO, stake, Surgical Replantation

Alcon, Aurion Biotech, majority stake, CEO replacement, cell therapy, corneal endothelial disease, AURN001, IPO dispute

MeiraGTx’s Gene Therapy Shows Significant Improvements in Motor Function and Quality of Life in Parkinson’s Disease Trial

6 months ago talkbio0Tagged AAV-GAD, Clinical Trials, dopamine, gamma-aminobutyric acid, gene therapy, MeiraGTx, Motor function (observable entity), Neurodegenerative Disorders, Parkinson 's disease, Phase 2 trial, production, Quality of life, Surgical Replantation

MeiraGTx, Gene Therapy, Parkinson’s Disease, AAV-GAD, Motor Function, Quality of Life, Clinical Trial, Phase 2 Trial, Neurodegenerative Disease, Dopamine Replacement, GABA Production

NuCana’s Chemotherapy Replacement Fails to Improve Survival in Phase II Trial

8 months ago talkbio0Tagged Colorectal Carcinoma, NuCana, Pharmacotherapy, Phase 2 Clinical Trials, Progression-Free Survival, Surgical Replantation

NuCana, chemotherapy replacement, Phase II trial, progression-free survival, colorectal cancer, NUC-3373